ReActiv8 Sales Training Assessment Review

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/126

flashcard set

Earn XP

Description and Tags

Flashcards covering the ReActiv8 Sales Training Assessment, including surgical procedures, clinical evidence (RESTORE and B trials), spinal anatomy, and sales methodology.

Last updated 12:35 AM on 7/1/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

127 Terms

1
New cards

Vertebral Body

The structural component of the vertebra identified in anatomical diagrams of the lumbar spine.

2
New cards

Superior Articulating Process

A process that extends upward from the vertebra to articulate with the adjacent vertebra above it.

3
New cards

Inferior Articulating Process

A process that extends downward from the vertebra to articulate with the adjacent vertebra below it.

4
New cards

Transverse Process

A small bony projection off the right and left side of each vertebra.

5
New cards

Spinous Process

The bony projection off the posterior (back) of each vertebra.

6
New cards

Lamina

The part of the vertebral arch that connects the spinous process to the transverse processes.

7
New cards

Pedicle

The segment of bone that connects the vertebral body to the transverse process.

8
New cards

ReActiv8 Specialized Tines

Anchors used to secure leads by bracketing the intertransversarii muscle.

9
New cards

Intertransversarii Muscle

The specific muscle which ReActiv8 leads bracket using specialized tines for anchoring.

10
New cards

Medial Branch of the Dorsal Ramus of L2

The primary target nerve of stimulation for the ReActiv8 system.

11
New cards

T12 (Twelfth Thoracic Vertebra)

The vertebra sitting superior to L1L1 identified as the lowest of two vertebrae with floating ribs.

12
New cards

Floating Ribs

Ribs that do not attach to the sternum, used to identify the T12T12 vertebra.

13
New cards

Intracept Procedure

A procedure that ablates the basivertebral nerve to cut off endplate pain signals.

14
New cards

Basivertebral Nerve Myelination

A feature of the nerve that helps explain the durability of Intracept because the nerve is not myelinated and does not tend to grow back.

15
New cards

ReActiv8 Core Problem Address

Segmental instability due to poor multifidus control, which differentiates it from the Intracept procedure.

16
New cards

Ordering Stock in Advance

A best practice that protects the plan and reduces last-minute risk to the patient and physician.

17
New cards

Standard ReActiv8 Implant Lead Count

An implant consisting of 22 leads plus 22 spares.

18
New cards

Class III Device Traceability

A core requirement that allows identification of every implanted component and affected patient if safety or labeling changes occur.

19
New cards

Initial IPG Set Up Programming

A task that should occur before the patient is on the table during an implant.

20
New cards

Positioning Goal

To achieve a neutral, flatter lumbar lordosis to reduce downstream difficulty with imaging and needle placement.

21
New cards

Five Salient Keys to a Successful Procedure

Fluoroscopy alignment, fascial entry point, final delivery needle position, depth of lead placement, and strain relief loop.

22
New cards

Lead Fixation Tug Test

A light test performed approximately 33 to 44 times during lead fixation.

23
New cards

Final Confirmation Testing

A procedure explicitly including a 2Hz2Hz twitch test and electrode impedance measurements at implant completion.

24
New cards

Normal ReActiv8 Impedance Range

A range defined in the manual as 150150 to 4999Ohms4999\,Ohms.

25
New cards

Top Left 4x4 Matrix Troubleshooting

The focus area for troubleshooting when an out-of-range value indicates a lead is plugged into port 11 to 44.

26
New cards

Intra-operative Twitch Stimulation Start

Stimulation that should typically begin at 1.0mA1.0\,mA.

27
New cards

Guven et al. Study Primary Aim

To assess the asymmetry in muscle morphology changes in patients undergoing unilateral lumbar medial branch radiofrequency neurotomy (RFN).

28
New cards

Fluoro Image Alignment Landmarks

The pedicles and spinous process of L3L3 which should be aligned/centered prior to placing guide needles.

29
New cards

Guidewire Posterior/Upward Deflection

An indicator that the intertransversarius structure has not been fully penetrated due to insufficient delivery needle advancement.

30
New cards

Ardeshiri et al. "Older Patient" Study Result

62%62\% of the oldest quartile experienced a 50%50\% reduction in pain after two years of restorative neurostimulation.

31
New cards

Lumbar Spine Proprioception

Regulation of spinal position, movement, and stability through perception or awareness.

32
New cards

Hodges et al. "Sheep Study" Stimulation Area

Stimulated muscle fascicles at L4L4 showed the greatest reduction in fibrotic changes due to neurostimulation.

33
New cards

Multifidus Muscle Role

The primary segmental stabilizer muscle of the lumbar spine.

34
New cards

ReActiv8 B Trial Robustness Factors

A blinded randomized sham-controlled trial including a variety of degenerative pathologies and reporting outcomes to 55 years.

35
New cards

Mainstay Medical Patient Activation Items

User Manual with ID/Implant Card, Activator, and Magnet.

36
New cards

ReActiv8 Electrode Length

A length of 3mm3\,mm.

37
New cards

[R]eframe Step Outcome

Agreement that multifidus dysfunction is a plausible and testable driver of mechanical low back pain.

38
New cards

Phase II Patient Identification Dysfunctional Patterns

Instability or Weakness, Flexion with Light Load, and Positional Transitions.

39
New cards

Patented Tines Location

Located on the distal and proximal sides of the first electrode of each ReActiv8 lead.

40
New cards

Midline Incision Placement

A 3-4 cm incision extending caudal from the identified AP fascial entry point.

41
New cards

ODI Improvement Consistency (1 Year)

70%70\% improvement in the RESTORE trial compared to 69%69\% in the ReActiv8-B trial.

42
New cards

Multifidus Lift Test (MLT)

A physical examination test that detects pain when motions are initiated.

43
New cards

RESTORE Subjects Average Age

An average age of 5151 years old.

44
New cards

RESTORE Subjects CLBP History

An average history of 1919 years of chronic low back pain.

45
New cards

Nociceptive Pain

Pain caused by injury or stress on non-neural tissues such as bones, ligaments, and muscles.

46
New cards

Hodges Sheep Study Fibrosis Primary Indicator

The levels of Collagen-I and Collagen-III used to analyze fibrosis in the multifidus muscle.

47
New cards

Three Subsystems of Spinal Stability

Muscles (active), brain (neural), and spine (passive).

48
New cards

Medial

Towards the midline.

49
New cards

Distal

Farther from a reference point or extremity.

50
New cards

Superior

The upper part or above a specific location.

51
New cards

Proximal

Closer to a point of reference or extremity.

52
New cards

Inferior

The lower part or below a specific location.

53
New cards

Lateral

Away from the midline.

54
New cards

Complaint Submission: Who

Requirement to specify who was affected by the incident.

55
New cards

Complaint Submission: What

Requirement to specify what happened in the incident.

56
New cards

Complaint Submission: When

Requirement to specify when the incident happened.

57
New cards

Complaint Submission: Where

Requirement to specify where the incident happened.

58
New cards

Complaint Submission: Product Identifiers

Requirement to provide the Part #, Serial #, or Lot #.

59
New cards

Altered Neuromuscular Control Presentation

The offloading of control to the superficial core (erector spinae) and multifidus dysfunction/atrophy.

60
New cards

ReActiv8-B Remitter Percentage (50% Pain Reduction)

72%72\% of patients at five years in the ReActiv8-B study.

61
New cards

Prone Instability Test (PIT) Action

Activates the posterior spinal musculature to emulate gross spinal stability.

62
New cards

ReActiv8 B Trial Observed Pathologies

Grade 1 spondylolisthesis, endplate modic changes, and facet arthropathy.

63
New cards

Oswestry Disability Index (ODI) Range

Measures the extent to which a person's functional level is restricted by disability.

64
New cards

Phase I Patient Identification Framework

The combination of Clinical History, MRI Biomarker, and Axial Back Pain.

65
New cards

Visual Analog Scale (VAS) Description

A pain scale comprised of a 10cm10\,cm line.

66
New cards

Three Most Important Functions of the Spine

Structural support, protection of the spinal cord/roots/internal organs, and flexibility/mobility.

67
New cards

RESTORE Trial Total Patients

203203 total patients across 2525 clinical sites.

68
New cards

Multifidus Radiologic Scan Type

MRI, commonly used to identify fatty infiltration.

69
New cards

Neuropathic Pain

Pain caused by disease or damage to the nerve tissue.

70
New cards

Multifidus Contraction Characteristics

Anticipatory control of intervertebral motion, slow twitch (Type I) fibers, and sub-max sustained effort at 1025%10-25\% of maximum contraction.

71
New cards

Sales Process Definition

A structured, step-by-step sequence of activities guiding from first contact through to close.

72
New cards

Reframe Step (Sales)

Inviting the physician to consider low back pain through a new lens of multifidus dysfunction.

73
New cards

Elevate Awareness Step (Sales)

Broadening the perspective beyond short-term pain relief to see the deeper issue of multifidus dysfunction.

74
New cards

Align Step (Sales)

Building empathy and urgency by aligning around the downstream effects of current approaches.

75
New cards

Create New Vision Step (Sales)

Jointly imagining what a more durable solution would look like.

76
New cards

Transition to Therapy Step (Sales)

Introducing ReActiv8 as the enabling solution that fulfills the new vision.

77
New cards

Incorporate Step (Sales)

Operationalizing adoption with clear roles, tools, and processes.

78
New cards

Validate Step (Sales)

Demonstrating impact through patient stories and measured results.

79
New cards

Acceler8 Step (Sales)

A stage in the ReActiv8 methodology associated with confirming results.

80
New cards

CLBP Nociceptive Nature

Observation that approximately two-thirds of chronic low back pain is predominantly nociceptive.

81
New cards

ReActiv8 Therapy Schedule

A recommended schedule of thirty minutes twice daily initiated by the patient.

82
New cards

Proprioception

The perception or awareness of the position and movement of the body.

83
New cards

Sales Methodology Definition

The set of principles, skills, and best practices that inform how a salesperson executes each step of the sales process.

84
New cards

Neuromuscular Control Loss Pattern

Repeated occurrences of adverse symptoms over time which become longer and more disabling.

85
New cards

REACTIV8 Sales Methodology behaviors

Teach, Tailor, and Take Control.

86
New cards

Yadav et al. RF Ablation Trend

A reduction of responders over time from 72%72\% at 1-month to approximately 24%24\% at 1-year.

87
New cards

Primary Endpoint of RESTORE

Disability measured by ODI.

88
New cards

Primary Endpoint of ReActiv8 B Study

Comparison of sham and active treatments at 120120 days in low back pain VAS.

89
New cards

RESTORE ODI Delta

A 16.8-16.8 point difference between the OMM group and the ReActiv8 group.

90
New cards

ReActiv8 Safety Profile

Demonstrated to be equivalent to or better than current standard neuromodulation techniques.

91
New cards

Facet Joint Innervation

Innervated by the same nerve that innervates the multifidus muscle.

92
New cards

B Study 5-Year ODI Reduction (20\ge 20 points)

61.1%61.1\% of patients reported this reduction in the ReActiv8 B study at five years.

93
New cards

B Study Pathology Incremental Success

Patients with Modic Changes did incrementally better than others.

94
New cards

Guven et al. RFN Morphology Results

A greater increase in fatty infiltration and decrease in functional cross-sectional area on the RFN side.

95
New cards

ICD-10 Code M62.85

The code for 'Dysfunction of the multifidus muscles, lumbar region'.

96
New cards

Multifidus Proprioceptive Receptors

Muscle spindles rich in receptors essential for detecting changes in muscle length and tension.

97
New cards

B Study 5-Year VAS Improvement Mean

A VAS improvement from 7.37.3 to 2.4cm2.4\,cm.

98
New cards

B Trial Average Pain Duration

An average of 1414 years of pain history.

99
New cards

Average Observed MRI Pathologies (B Trial)

2.32.3 pathologies per participant.

100
New cards

B-pivotal Trial 5-Year Completion Count

126126 participants completed the five-year follow-up.